Objectives: To investigate the association between the presence of a genetic island inserted within the sapABCDF operon of Salmonella Typhi and the susceptibility to antimicrobial peptides.
Introduction
Salmonella enterica serovars are a group of Gram-negative pathogens that infect animals and humans. Systemic infections, gastroenteritis and septicaemia can occur depending on the animal species and the bacterial serovar. Salmonella enterica serovar Typhimurium (Salmonella Typhimurium) can infect a wide range of hosts causing different symptoms, including a systemic disease in mice. In contrast, Salmonella enterica serovar Typhi (Salmonella Typhi) infects only humans and is the aetiological agent of typhoid fever, a disease that causes significant morbidity and mortality worldwide. 1 -4 Antimicrobial resistance is a major public health problem in Salmonella Typhi. 5 Timely treatment with appropriate antimicrobials is important for reducing the mortality associated with enteric fever. 5 The rapid emergence of resistant bacterial strains requires the development of alternative treatments to control this disease. Antimicrobial peptides (APs) are essential elements of innate immunity that have been identified in organisms ranging from bacteria to humans. 6, 7 The main features of APs include short length (,100 amino acids), positive charge and amphiphilicity. Despite these similarities APs show significant differences in both structure and function. 8 Initial contact of APs with the target cell is mediated by electrostatic interactions between the positively charged peptides and the negatively charged bacterial membrane. While several APs interact with the cytoplasmic membrane and then intracellularly, others exert their effect by acting on specific intracellular targets. It has been suggested that APs may be useful for the treatment of bacterial infections as several of them exhibit high antibacterial efficacy in vitro. Nevertheless, some bacteria have developed systems to tolerate the antimicrobial effect of APs. One such element is the sapABCDF operon that was first described in Salmonella Typhimurium. 10, 11 This operon is present in numerous Gram-negative organisms such as Erwinia chrysanthemi, 12, 13 Haemophilus influenzae, 14, 15 Vibrio fischeri 16, 17 and Proteus mirabilis. 18 The sap operon of Salmonella Typhimurium contains five genes that are polycistronically transcribed and encodes a peptide transporter system of the 'ATP-binding cassette' family (ABC), also known as traffic ATPases.
11 ABC transporters are involved in a variety of physiological functions in both prokaryotes and eukaryotes, including detoxification of noxious compounds and ion transport. 19 The Salmonella Typhimurium SapABCDF transporter system confers resistance to small cationic peptides such as protamine. 10 This molecule is a highly cationic peptide of 32 amino acids containing 21 arginine residues and is found in fish sperm nuclei. 20 Protamine exerts a broad-spectrum activity against Gram-positive and Gram-negative microorganisms, 10, 21, 22 representing an attractive model for studying the antimicrobial effects of APs. 12,13,21 -24 Unlike Salmonella Typhimurium, the sapABCDF operon of Salmonella Typhi has not yet been characterized. However, it has been reported that this human pathogen is more sensitive to protamine than Salmonella Typhimurium. 25 Moreover, preliminary studies in our laboratory suggested the presence of a genetic island inserted within the sap operon of this bacterium. The aims of this research were to determine the prevalence of the genetic island GICT18/1 among Salmonella isolates and to determine whether a relationship exists between the genetic island inserted within the sapABCDF operon of Salmonella Typhi and the AP susceptibility phenotype reported for this pathogen.
Materials and methods

Bacterial strains, growth media and culture conditions
Clinical strains of Salmonella Typhi were obtained from the Hospital of Infectious Disease Lucio Có rdova of Santiago, Chile, and have been described elsewhere. 26 -28 Twenty-six strains were isolated from blood samples of patients with typhoid fever. Salmonella Typhi Ty2 was obtained from the Instituto de Salud Pú blica of Santiago, Chile. Serovars of Salmonella enterica subspecies I were from the Salmonella reference collection B (SARB) 29 and are listed in Table S1 [available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)]. Bacterial strains were grown routinely in Luria-Bertani (LB) broth (Bacto Tryptone, 10 g/L; Bacto Yeast Extract, 5 g/L; NaCl 5 g/L) at 378C with shaking. Media were supplemented with kanamycin (50 mg/L), ampicillin (100 mg/L) and L-arabinose (2 mg/mL) as required. Solid media were prepared by addition of agar (15 g/L). PBS buffer contained 55 mg/mL NaH 2 PO 4 . 7H 2 O, 15 mg/mL K 2 HPO 4 and 4.25 mg/mL NaCl, and was adjusted to pH 7.4.
Genomic structure analyses of the sapABCDF operon
Salmonella Typhi CT18 (GenBank accession no. AL627270.1) 30 was used as the genome reference to compare a number of Salmonella enterica genome sequences. Genome sequences of Salmonella Typhi Ty2, 31 Salmonella Typhimurium LT2, 32 Salmonella Typhimurium 14028s, 33 Salmonella Gallinarum 287/91, 34 Salmonella Choleraesuis SC-B67, 35 Salmonella Enteritidis PT4, 34 Salmonella Paratyphi A ATCC 9150, 36 Salmonella Agona SL483, Salmonella Dublin CT-02021853, Salmonella Heidelberg SL476-SL486, Salmonella Javiana GA-MM04042433, Salmonella Kentucky CDC191-CVM29188, Salmonella Newport SL254-SL317, Salmonella Saintpaul SARA23-SARA29 and Salmonella Schwarzengrund CVM19633-SL480 were obtained from the National Center for Biotechnology Information (NBCI, http://www.ncbi.nlm.nih.gov/sutils/genom_table. cgi). Genomic sequences of Salmonella Typhimurium DT2, Salmonella Typhimurium DT104, Salmonella Typhimurium DT2358, Salmonella Typhimurium SL1344 and 17 Salmonella Typhi isolates 37 were obtained from the Sanger Institute (http://www.sanger.ac.uk/Projects/Salmonella/). Salmonella Dublin and Salmonella Pullorum were obtained from the University of Illinois (www.Salmonella.org/genomics/). Nucleotide sequence comparisons and alignments were made using bioinformatics tools provided by the web sites cited above.
PCR analyses and deletion of the GICT18/1 genetic island of Salmonella Typhi PCR amplifications were performed in a standard volume of 25 mL, except for the amplification of GICT18/1 which was performed in 12.5 mL. Primers E12D (5 ′ -AAA AGG AGA CTT CGC CAT AGC G-3 ′ ) and E12R (5 ′ -CAG CAC TAT TGA GGT CTA CG-3 ′ ) were used to amplify GICT18/1 of Salmonella Typhi. Pairs of primers SB-1 (5
′ ) were used to amplify PCR products corresponding to the sapB and sapC genes of the Salmonella Typhi STH2370 clinical strain, respectively. The reaction mixture contained 1× buffer, 3 mM MgCl 2 , 200 mM of each deoxynucleoside triphosphate, 1 mM of each primer, 100 ng of template DNA and 2 U of DNA polymerase (Invitrogen). Amplification conditions included 30 cycles (948C for 30 s, 588C for 45 s and 728C for 3 min) and a final extension step at 728C for 10 min. Salmonella enterica chromosomal DNA was prepared as described previously 26 -28 and used as template in the PCR experiments. Deletions of Salmonella Typhi GICT18/1 and GICT18/1+sapCDF chromosomal elements were achieved by the method described by Datsenko and Wanner. 38 These deletions were constructed in the Salmonella Typhi STH2370 clinical strain, yielding the Salmonella Typhi DGICT18/1 and Salmonella Typhi DGICT18/1-sapCDF mutant strains, respectively (Table S1 ). PCR primers were designed with 40 nucleotide sequences homologous to the respective flanking regions of the targets (GICT18/1 genetic island or GICT18/1-sapCDF) followed by 20 nucleotides complementary to the template plasmid pKD4.
The direct and reverse primers used for deleting GICT18/1 were H1P1R12 (5 ′ -TAC TCG TTT TAT TTT TGT TTA CCA TGC TTT ATG TCT TTT  GTG TAG GCT GGA GCT GCT TCG-3 ′ ) and H2P2R12 (5 ′ -AAT AAA AAT ATC ATT AAA TCA AAA AGT TAT GCT TTT ATT TCA TAT GAA TAT CCT CCT TAG-3 ′ ), respectively. The primers used for deletion of DGICT18/ 1-sapCDF were H1WR12+sap (5 ′ -GGG TAT TTG TGT CGC TTA GCG ATC CTT TCG CCA TGC GCT ATG TAG GCT GGA GCT GCT TCG-3 ′ ) and H2P2-sapCDF (5 ′ -CAA AAG ACA TAA AGC ATG GTA AAC AAA AAT AAA ACG AGT ACA TAT GAA TAT CCT CCT TAG-3 ′ ). PCR products were purified using Qiagen mini columns and used to transform Salmonella Typhi/ pKD46 grown at 308C in LB supplemented with 10 mM L-arabinose and 100 mg/L ampicillin. Bacteria were spread on LB agar plates supplemented with kanamycin and incubated at 378C to select for the allelic exchange and cure plasmid pKD46. Subsequent deletion of the antibiotic-resistant cassette was confirmed by PCR.
DNA sequencing of sapB and sapC genes PCR products obtained for the sapB and sapC genes of Salmonella Typhi STH2370 were used for DNA sequencing at Macrogen Corp. (Rockville, Loss of sapABCDF function in Salmonella enterica serovar Typhi 1625 JAC MD, USA). DNA sequences were compared with the genome sequences of Salmonella Typhi CT18, 30 Salmonella Typhi Ty2, 31 Salmonella Typhimurium LT2 32 and Salmonella Typhimurium 14028s 33 using the BLAST program (http://www.ncbi.nlm.nih.gov/BLAST/).
Cloning of the GICT18/1 genetic island of Salmonella Typhi
The PCR product of the Salmonella Typhi GICT18/1 genetic island was directly cloned into the pCC1 vector according to the manufacturer's instructions (CopyControl TM PCR Cloning Kit, Epicentre) to yield the plasmid pRP012 (Table S1 ). The presence of GICT18/1 was confirmed by PCR and restriction endonuclease assays.
Detection of the sapDF transcript
RNA samples were obtained as described previously. 39 Briefly, cells were grown overnight in LB broth at 378C with shaking. Total RNA was extracted and purified by TRIzol (Invitrogen) and treated with RNase-free DNAse (Promega). RT-PCR amplification was performed with 3 mg of DNase I-treated RNA using Superscript II RT (Invitrogen) following the instructions provided by the vendor. Amplification included 35 cycles (948C for 30 s, 588C for 45 s and 728C for 90 s) followed by a 5 min extension at 728C to ensure full extension of the amplified fragments. Primers SF-3d (5 ′ -GAA GTC AAG AAT CTG TGA AA-3 ′ ) and SF-2 (5 ′ -GGC GCG AAA AAT CAT CTC TAT GCC-3 ′ ), designed on the basis of the Salmonella Typhi strain CT18, 30 were used to amplify the hybrid sapD and sapF fragment. Reverse transcription of 16S rRNA was used as a positive control. 40 A negative control consisted of the same amplification mixture except that the reverse transcriptase enzyme was omitted. Amplified products were fractionated on 1.5% agarose gels, stained with ethidium bromide and visualized under a UV source.
Antimicrobial susceptibility
To test the bacterial susceptibility to APs, protamine sulphate, mellitin and human defensin-1 (HNP-1) were used as described previously. 10, 25, 41 Stock solutions of protamine sulphate and mellitin (Calbiochem) were made by dissolving appropriate amounts of solid peptide in PBS (pH 7.4). Solid peptide HNP-1 (Sigma) was dissolved in 0.01% acetic acid. Cells were grown at 378C for 16 h in LB broth, diluted in LB (1:20) and grown until mid-exponential phase. Cells were centrifuged, washed twice with PBS (pH 7.4) and diluted (1:20 000) in the same buffer. Aliquots of 50 mL were added into a 96-well microtitre tray and mixed with 50 mL of peptide solution. Controls included bacterial cells (50 mL) diluted in PBS (50 mL), and peptide solution (50 mL) diluted in PBS (50 mL). Trays were incubated at 378C with shaking for 1 h (protamine and mellitin) or 2 h (HNP-1) and placed on ice. Incubation mixtures were diluted 10-fold in PBS and aliquots of 100 mL spread on LB plates and incubated at 378C overnight. Results were expressed as the percentage of bacteria surviving compared with those in the control with no peptide added. Statistical analyses were performed using one-way analysis of variance (ANOVA) with P values of , 0.05 considered significant.
Results
Insertion of GICT18/1 within the sapABCDF operon of Salmonella Typhi
Previous studies in our laboratory indicated that Salmonella Typhi has a genetic insertion interrupting the sapABCDF operon. To further investigate this finding we looked at the genomic structure of the sapABCDF operon reported for the CT18 strain 30 that is currently available in GenBank. Results showed that the Salmonella Typhi sapABCDF operon contains a 4.1 kb region that is absent in Salmonella Typhimurium, which has an intact operon (Figure 1 ). Nine open reading frames (ORFs) of low G +C content (42.5%) and encoding peptides from 45 to 166 residues [STY1358 through STY1367; Table S2 , available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)] are found in the 4.1 kb DNA insertion. This insertion is located between the sapB and sapC genes of the sap operon and does not affect the coding sequences of these two genes as determined by PCR and DNA sequencing (data not shown). This 4.1 kb insertion is a genetic island that we named GICT18/1.
To determine whether GICT18/1 is a common feature of Salmonella Typhi, PCR experiments were conducted using Rodas et al.
DNA isolated from the reference strain Ty2 and 26 Chilean clinical strains. Forward and reverse primers flanking the GICT18/1 insertion site ( Figure 1 ) were designed to assess the presence of this genetic island. Results showed an amplicon of 4.5 kb in all PCR amplifications, suggesting that GICT18/1 is found in all Salmonella Typhi strains analysed (data not shown). The nucleotide sequence of the amplicon obtained from Salmonella Typhi STH2370 was determined and compared with the Salmonella Typhi CT18 sequence, showing an identical genetic island composed of 4057 nucleotides (data not shown).
Detection of the GICT18/1 genetic island in other Salmonella enterica serovars
The presence of GICT18/1 in the genomes of 15 Salmonella enterica serovars was determined using nucleotide sequences obtained from GenBank. Results showed that GICT18/1 was only found in Salmonella Paratyphi A (98% identity), Salmonella Schwarzengrund (96% identity) and Salmonella Javiana (96% identity) (Figure 1 ). These results suggest that GICT18/1 is infrequent in Salmonella enterica serovars. PCR amplifications using DNA from Salmonella Typhimurium, Salmonella Pullorum, Salmonella Gallinarum, Salmonella Montevideo and 32 other serovars of the Salmonella enterica reference collection B (SARB) 29 showed amplicons of 0.5 kb in Salmonella Typhimurium and 23 other serovars. Amplicons of 4.5 kb were detected in Salmonella Montevideo, Salmonella Brandenburg, Salmonella Enteritidis (SARB30), Salmonella Panama, Salmonella Paratyphi A, Salmonella Reading, Salmonella Rubislaw, Salmonella Schwarzengrund, Salmonella Typhi (SARB63), Salmonella Typhisuis and Salmonella Wien ( Table 1 ), suggesting that the GICT18/1 island is present in these strains interrupting the sapABCDF operon.
Salmonella Typhi susceptibility to APs associated with the sapABCDF operon
Because Salmonella Typhi has GICT18/1 inserted within the sap operon, the function of this operon in regard to bacterial tolerance to the APs protamine, mellitin and HNP-1 was investigated. Bacterial susceptibility to these peptides has been associated with the sapABCDF operon in Salmonella Typhimurium.
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A Salmonella Typhi mutant was constructed in which GICT18/1 was fully removed by the method of Datsenko and Wanner. 38 This mutant, referred to as Salmonella Typhi DGICT18/1, was exposed to protamine and mellitin for 1 h 10,25 and to HNP-1 for 2 h. 41 Salmonella Typhi DGICT18/1 showed a susceptibility pattern similar to that of Salmonella Typhimurium and a much lower susceptibility to protamine than that of Salmonella Typhi STH2370 (Figure 2 ). This suggests that removal of the GICT18/1 genetic island reinstates the sap operon AP resistance function. We supported this affirmation by testing protamine susceptibility in the Salmonella Typhi DGICT18/1-sapCDF mutant strain, which showed a similar pattern to that of Salmonella Typhi STH2370 wild-type. Moreover, complementation of Salmonella Typhi DGICT18/1 with the recombinant plasmid pRP012 showed the same phenotype as that shown by the mutant (Figure 2) , suggesting that the susceptibility pattern observed initially in Salmonella Typhi STH2370 is not a contribution of the nine ORFs encoded in this genetic island but is a consequence of the insertion itself. No significant differences in the AP pattern were detected when melittin and HNP-1 were used (data not shown).
Detection of the Salmonella Typhi sapDF transcribed fragment
The products of Salmonella Typhimurium sapD and sapF exhibit similarity to ATP-binding proteins such as OppD and OppF that are involved in the uptake of oligopeptides. 11 In fact, it was reported that mutations in sapD and sapF result in hypersusceptibility to protamine in Salmonella Typhimurium. 11 The high susceptibility of Salmonella Typhi STH2370 to protamine suggests that this behaviour might be related to sapD and sapF. Amplified fragments suggestive of sapD and sapF transcription were not 
Loss of sapABCDF function in Salmonella enterica serovar Typhi 1627 JAC detected in the Salmonella Typhi STH2370 clinical strain. A DNA fragment of 340 bp was observed in the mutant Salmonella Typhi DGICT18/1 (Figure 3 ), suggesting that incorporation of GICT18/1 within the sap operon of the Salmonella Typhi STH2370 genome affects expression of genes located downstream of the point of insertion.
Discussion
APs are a unique and diverse group of molecules that are divided into subgroups on the basis of their amino acid composition and structure. 7, 42 These peptides are produced by many tissues and cell types in a variety of plant and animal species. Since APs have been demonstrated to kill both Gram-negative and Grampositive bacteria, this property makes it difficult to come up with a universal model to study their mechanisms of action. Broad-spectrum peptides such as protamine have been used as a model to study the biological properties of APs. 10, 21, 22 Salmonella Typhimurium is the first microorganism in which a set of genes has been reported to be associated with antibacterial response to protamine. 10 One such element is the operon sapABCDF that has been found in several Gram-negative pathogens. 12 -18 This study reports that a 4.1 kb genetic island (GICT18/1) interrupts the sapABCDF operon in the Salmonella Typhi genome as determined by bioinformatic analyses and PCR experiments. We also demonstrate that a relationship exists between the insertion of GICT18/1 within the sapABCDF operon and the enhanced susceptibility to the AP protamine exhibited by this pathogen.
The sapABCDF operon consists of genes organized in a single transcriptional unit. 11 These genes show similarity to the ABC transporter system, highlighting the evolutionary relevance of the sap operon. 13 -18,43 The stable integration of the 4.1 kb genetic island in the sapABCDF operon of Salmonella Typhi raises the question of whether such a chromosomal insertion conferred any evolutionary advantage on this pathogen. This genetic island is rarely found in Salmonella enterica serovars included in this study. Interestingly, those Salmonella enterica serovars that harbour GICT18/1 also carry SPI-18, a pathogenicity island that encodes a gene for a haemolysin in Salmonella Typhi. All these serovars have been reported to cause a systemic Rodas et al.
infection in humans. 27,44 -46 The insertion of GICT18/1 might be advantageous to Salmonella Typhi by providing novel functions to this bacterium. For instance, the product of STY1364 (one of the ORFs in the GICT18/1 island) has been found associated with the Salmonella Typhi proteome when the cells are grown under a low Mg 2+ concentration, a condition related to the intracellular environment in the Salmonella-containing vacuole (SCV). 47 In addition, STY1362 and STY1364 exhibit a high degree of similarity to artA and artB, two genes displaying ADP-ribosyltransferase activity in Salmonella Typhimurium DT104. 48 -50 Although the nine ORFs encoded by GICT18/1 have not yet been well characterized, our results suggest that they have no role in protamine susceptibility because when Salmonella Typhi DGICT18/1 was complemented with pRP012 carrying GICT18/1 no modification of this susceptibility was observed. Therefore, the insertion of GICT18/1 within the Salmonella Typhi sap operon is responsible for the phenotype. In addition, the absence of an RT-PCR product from sapDF genes located downstream of GICT18/1 indicate that the polycistronic transcript is not produced.
The Salmonella Typhi wild-type strain used in this study is only susceptible to protamine and not to mellitin and HNP-1, suggesting that additional genes are involved in AP resistance. This is supported by observations that Salmonella Typhi expresses a number of genes, including phoP, pqaB, uglT and pagP, as part of the AP resistance response inside human macrophages. 51 In addition, Eswarappa et al. 52 have reported that another operon known as yejABEF is responsible for protamine resistance in Salmonella Typhimurium. The genes of the Salmonella Typhi yejABEF operon have not been characterized. However, our in silico nucleotide sequence analyses of the Salmonella Typhi genome indicate that a group of ORFs, STY2452, STY2453, STY2454 and STY2455, have a high level of identity with Salmonella Typhimurium yejABEF.
In summary, we report that insertion of the genetic island GICT18/1 in the sap operon of Salmonella Typhi is responsible for the high susceptibility to protamine in this pathogen. This genetic insertion is rarely found in other closely related Salmonella enterica serovars. To the best of our knowledge, this is the first report of a genetic island inserted within an operon.
